ARF1 and neoplasm: Here, in the Drosophila stem cell tumor system, a screening of over 100 chemicals, modified based on Exo2, led to the discovery of two new potent small‐molecule inhibitors of Arf1 for cancer therapy, denoted as DU101 and DU102.